Graham Elliott
Managing Director
clinical research
Derphartox BV
Netherlands
Biography
Dr. Elliott obtained his Master’s in Toxicology and his Ph.D. from Surrey University, Guilford, UK. He moved to Erasmus University, Rotterdam in 1981, where he researched the role of eicosanoids in immune-inflammatory reactions, before moving to TNO (Netherlands Institute for Applied Research) in 1988. During his time at TNO Dr. Elliott developed a number of alternative in vitro models for investigating acute interactions between chemical agents and the skin and humanized models for investigating chronic interactions. Derphartox was established in 2001 by Dr. Elliott with the aim of exploiting these models for pharmaceutical research.
Research Interest
Clinical and Laboratory Research
